EXT608 is a long-acting PTH derivative under investigation for the treatment of hyperparathyroidism.
EXT608 is a long-acting PTH derivative under investigation for the treatment of hyperparathyroidism.
No indication information available.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.